New Delhi, Jan 23 (PTI) Dr Reddy's Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third quarter ended December 31, 2024.

The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal.

Also Read | 8th Pay Commission Pension Calculator: How Will Pension Hike Impact Central Govt Employees? Know About Fitment Factor and Other Key Details.

Revenue increased to Rs 8,359 crore in the quarter from Rs 7,215 crore in the year-ago period, Dr Reddy's Laboratories said in a statement.

"We delivered double-digit growth aided by our newly acquired NRT business, new launches and improved operational efficiencies. We remain committed to addressing patient needs by advancing healthcare through access, affordability and innovation," company's Co-Chairman & MD G V Prasad said.

Also Read | Netaji Subhas Chandra Bose Jayanti 2025 Date, History and Significance: Know About the Day Celebrating Indian Nationalist’s 128th Birth Anniversary.

Dr Reddy's shares on Thursday ended 0.54 per cent down at Rs 1,289.35 apiece on BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)